Ganesh Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.90 M
as on 16-11-2024
- Company Age 42 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 49.16 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit -261.68%
(FY 2023)
- Ebitda 54.49%
(FY 2023)
- Net Worth -3.52%
(FY 2023)
- Total Assets 152.77%
(FY 2023)
About Ganesh Medicament
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.90 M.
The company has closed loans amounting to ₹49.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramakant Pilani, Raunak Pilani, and Manjudevi Pilani serve as directors at the Company.
- CIN/LLPIN
U24200MH1982PTC028266
- Company No.
028266
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ganesh Medicament?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raunak Pilani  | Director | 01-Sep-2017 | Current |
| Ramakant Pilani | Director | 03-Nov-2010 | Current |
| Manjudevi Pilani | Director | 29-Sep-2000 | Current |
Financial Performance and Corporate Structure Insights of Ganesh Medicament.
Ganesh Medicament Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 261.68% decrease in profit. The company's net worth dipped by a decrease of 3.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ganesh Medicament?
In 2023, Ganesh Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vidarbha Lifecare Private LimitedActive 13 years 11 monthsRamakant Pilani and Manjudevi Pilani are mutual person
Susram Financial Services & Realty Private LimitedActive 16 years 11 monthsRamakant Pilani and Raunak Pilani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Feb 2019 | ₹12.00 Cr | Satisfied |
Others Creation Date: 20 Jan 2018 | ₹9.50 Cr | Satisfied |
Others Creation Date: 04 Aug 2016 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Ganesh Medicament?
Unlock and access historical data on people associated with Ganesh Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ganesh Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganesh Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
